The generic name of Weigantin is Hepatic Hydrolyzed Peptide Injection, and the main ingredient is a sterile aqueous solution containing polypeptides, nucleic acids, and amino acids extracted from the liver of healthy pigs by enzymatic hydrolysis. Hepatic Hydrolyzed Peptide Injection is mainly used in the adjuvant treatment of chronic hepatitis, cirrhosis and other diseases. Its pharmacological effect can reduce protein decomposition, promote protein synthesis, but also can promote the regeneration and proliferation of normal liver cells, carbon tetrachloride-induced hepatocellular injury to play a good protective role, reduce ghrelin aminotransferase, and promote the recovery of diseased liver tissue. Patients who are allergic to hepatic hydrolyzed peptide injection are prohibited. It is contraindicated in patients with severe azotemia in hepatic coma and disorders of amino acid metabolism. Since the drug is a biological preparation, care should be taken when using it, and when the product changes in character, becomes turbid or precipitates, it should be prohibited from use. Drugs need to be under the guidance of a doctor, reasonable use of medication, not unauthorized use of medication, in order to avoid the emergence of serious adverse consequences.